EP4706643A2 — Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
Assigned to Shanghai Aucta Pharmaceuticals Co Ltd · Expires 2026-03-11 · 0y expired
What this patent protects
The present invention relates to a pharmaceutical composition of lacosamide and a pharmaceutical preparation thereof. The pharmaceutical composition comprises extended release multiparticulates, wherein each of the extended release multiparticulates comprises: (a) a drug-loaded c…
USPTO Abstract
The present invention relates to a pharmaceutical composition of lacosamide and a pharmaceutical preparation thereof. The pharmaceutical composition comprises extended release multiparticulates, wherein each of the extended release multiparticulates comprises: (a) a drug-loaded core, comprising lacosamide or a pharmaceutically acceptable salt thereof; and (b) an extended release layer coating the drug-loaded core. The present invention also provides an extended release preparation of lacosamide for once daily oral administration.
Drugs covered by this patent
- Vimpat (lacosamide) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.